There are 3 major trial results for first line use of SIRT, all...

There are 3 major trial results for first line use of SIRT, all due mid next year. Two HCC trials for primary liver cancer (SARAH and SIRveNIB). Third result is for metastatic colon cancer (combined overall survival data from SIRFLOX, FOXFIRE and FOXFIRE Global studies).

http://www.sirtex.com/au/clinicians/hcc-clinical-studies/

http://www.sirtex.com/au/clinicians/ongoing-clinical-studies/

If any of these trials are positive then SIRT will be used earlier in treatment algorithms. Dose sales will rebound and today's prices will look a bargain. I expect results will be presented at the ASCO meeting in May, but there could be an Ann earlier.